Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|October 13, 2006
[Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis]Lone N Troelsen, Søren Jacobsen
The Journal of Rheumatology|January 30, 2010
Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin?Lone N Troelsen, Peter Garred, Søren Jacobsen
Ugeskrift for Laeger|December 13, 2005
[Hypereosinophilic syndrome]Lone N Troelsen, Lotte W Boisen, Ove Andersen
Arthritis and Rheumatism|December 30, 2006
Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritisLone N Troelsen, Peter Garred, Hans Ole Madsen, et al.
The Journal of Rheumatology|July 3, 2010
Genetically determined serum levels of mannose-binding lectin correlate negatively with common carotid intima-media thickness in systemic lupus erythematosusLone N Troelsen, Peter Garred, Buris Christiansen, et al.
Molecular Immunology|November 27, 2009
Double role of mannose-binding lectin in relation to carotid intima-media thickness in patients with rheumatoid arthritisLone N Troelsen, Peter Garred, Buris Christiansen, et al.
JAMA|July 4, 2017
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical TrialCarol Wysham, Anuj Bhargava, Louis Chaykin, et al.
The Journal of Rheumatology|January 17, 2012
IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritisLone N Troelsen, Søren Jacobsen, Jodie L Abrahams, et al.
Diabetologia|January 28, 2020
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trialAthena Philis-Tsimikas, David C Klonoff, Kamlesh Khunti, et al.
Pageof 1